Utilization of a cell‐penetrating peptide‐adaptor for delivery of human papillomavirus protein E2 into cervical cancer cells to arrest cell growth and promote cell death
暂无分享,去创建一个
J. McMurry | Robert Dickson | C. Chrestensen | S. Nowak | S. Ho | Julia C Lecher | Hope L. Didier | Lauren R. Slaughter | Juana C. Bejarano | Scott J. Nowak
[1] J. McMurry,et al. A reversible cell penetrating peptide-cargo linkage allows dissection of cell penetrating peptide- and cargo-dependent effects on internalization and identifies new functionalities of putative endolytic peptides , 2022, Frontiers in Pharmacology.
[2] Jonathan L. McMurry,et al. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos , 2021, bioRxiv.
[3] A. Składanowski,et al. Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells , 2021, International journal of molecular sciences.
[4] Jonathan L. McMurry,et al. Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem , 2017, Biomolecular concepts.
[5] Akila N. Viswanathan,et al. Cervical cancer in low and middle income countries: Addressing barriers to radiotherapy delivery , 2017, Gynecologic oncology reports.
[6] Jonathan L. McMurry,et al. A versatile cell-penetrating peptide-adaptor system for efficient delivery of molecular cargos to subcellular destinations , 2017, PloS one.
[7] E. Garrido,et al. Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression , 2016, Oncotarget.
[8] P. Fisher,et al. Gene Therapies for Cancer: Strategies, Challenges and Successes , 2015, Journal of cellular physiology.
[9] Zhiqiang Liu,et al. Western Blot: Technique, Theory and Trouble Shooting , 2014, North American journal of medical sciences.
[10] Wim Quint,et al. The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.
[11] Ping-Chang Yang,et al. Western Blot: Technique, Theory, and Trouble Shooting , 2012, North American journal of medical sciences.
[12] Y. Jacob,et al. Large Scale Genotype Comparison of Human Papillomavirus E2-Host Interaction Networks Provides New Insights for E2 Molecular Functions , 2012, PLoS pathogens.
[13] Jonathan L. McMurry,et al. Rate, affinity and calcium dependence of nitric oxide synthase isoform binding to the primary physiological regulator calmodulin , 2011, The FEBS journal.
[14] J. Beckmann,et al. Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. , 2007, Biochimica et biophysica acta.
[15] Shwu‐Yuan Wu,et al. Dynamic Localization of the Human Papillomavirus Type 11 Origin Binding Protein E2 through Mitosis While in Association with the Spindle Apparatus , 2006, Journal of Virology.
[16] L. Banks,et al. Regulation of Human Papillomavirus Type 16 E7 Activity through Direct Protein Interaction with the E2 Transcriptional Activator , 2006, Journal of Virology.
[17] P. Stern,et al. Diffusible VP22-E2 protein kills bystander cells and offers a route for cervical cancer gene therapy. , 2005, Human gene therapy.
[18] F. Méchali,et al. High-Risk But Not Low-Risk HPV E2 Proteins Bind to the APC Activators Cdh1 and Cdc20 and Cause Genomic Instability , 2005, Cell cycle.
[19] L. Banks,et al. Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein , 2005, Oncogene.
[20] P. Stern,et al. Herpes simplex virus VP22–human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death , 2004, Biotechnology and applied biochemistry.
[21] Shwu‐Yuan Wu,et al. Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] Karl Münger,et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein , 2001, Oncogene.
[23] L. Banks,et al. The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.
[24] P. Stern,et al. The Human Papillomavirus (HPV) 16 E2 Protein Induces Apoptosis in the Absence of Other HPV Proteins and via a p53-dependent Pathway* , 2000, The Journal of Biological Chemistry.
[25] E. Androphy,et al. Transactivation-Competent Bovine Papillomavirus E2 Protein Is Specifically Required for Efficient Repression of Human Papillomavirus Oncogene Expression and for Acute Growth Inhibition of Cervical Carcinoma Cell Lines , 1998, Journal of Virology.
[26] M. Yaniv,et al. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis , 1997, The EMBO journal.
[27] P. Howley,et al. Suppression of cellular proliferation by the papillomavirus E2 protein , 1995, Journal of virology.
[28] P. Lambert,et al. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.
[29] J. Settleman,et al. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene , 1993, Journal of virology.
[30] P. Howley,et al. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Wagatsuma,et al. Analysis of integrated human papillomavirus type 16 DNA in cervical cancers: amplification of viral sequences together with cellular flanking sequences , 1990, Journal of virology.
[32] M. Yaniv,et al. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes , 1989, Journal of virology.
[33] L. Gissmann,et al. The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. , 1985, The Journal of general virology.
[34] Wolfgang Mayer,et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.